Status:
COMPLETED
Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)
Lead Sponsor:
Western Sky Medical Research
Collaborating Sponsors:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
This study will compare the amount of bronchial tube relaxation from the Formoterol medicine contained in the Symbicort pressure Metered Dose Inhaler(pMDI)(a combination of Budesonide, a steroid, and ...
Detailed Description
Sixteen subjects will receive treatment in a cross-over design. They will inhale Symbicort 160/4.5 two inhalations in the manner prescribed in the approved package insert. The second intervention will...
Eligibility Criteria
Inclusion
- Asthma with 15% or more increase in Forced expiratory volume at 1 second (FEV-1) after 180-360 mcg of albuterol pMDI
Exclusion
- Any illness or condition which might place subject at risk in the study;e.g. some cardiovascular disorders Inability to understand and sign informed consent
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00915538
Start Date
July 1 2009
End Date
August 1 2009
Last Update
August 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Sky Medical Research
El Paso, Texas, United States, 79903